Masayuki Hino

Discontinuation of dasatinib in patients with chronic myeloid leukaemia who have maintained deep molecular response for longer than 1 year (DADI trial): a multicentre phase 2 trial

Jun Imagawa, Hideo Tanaka, Masaya Okada et al. · The Lancet Haematology · 2015 · 300 citations

Medicine, Hematology, Oncology +4

Transmission of symptomatic parvovirus B19 infection by fibrin sealant used during surgery

Masayuki Hino, Osamu Ishiko, Kenichi Honda et al. · British Journal of Haematology · 2000 · 243 citations

Medicine, Infectious Diseases, Surgery +12

Notable effects of angiotensin II receptor blocker, valsartan, on acute cardiotoxic changes after standard chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisolone

Hirohisa Nakamae, Kei Tsumura, Yoshiki Terada et al. · Cancer · 2005 · 243 citations · Full text

Medicine, Oncology, Pharmacology +16

Platelet P-Selectin Expression Is Associated With Atherosclerotic Wall Thickness in Carotid Artery in Humans

Hidenori Koyama, Takaaki Maeno, Shinya Fukumoto et al. · Circulation · 2003 · 162 citations

Medicine, Cardiology, Hematology +15

Cytokine-Specific Activation of Distinct Mitogen-Activated Protein Kinase Subtype Cascades in Human Neutrophils Stimulated by Granulocyte Colony-Stimulating Factor, Granulocyte-Macrophage Colony-Stimulating Factor, and Tumor Necrosis Factor-

Kenichi Suzuki, Masayuki Hino, Fumihiko Hato et al. · Blood · 1999 · 157 citations

Life Sciences, Cell Biology, Immunology +14